Search
Items tagged with: cancer
"The Trump administration is backing Monsanto in its effort to get the Supreme Court to shield it from liability over cancer claims related to its Roundup weedkiller, a move that could anger the Trump administration’s allies in the Make America Healthy Again (MAHA) movement."
thehill.com/policy/energy-envi…
#PublicHealth #environment #toxins #chemicals #cancer #monsanto #EPA #courts #SCOTUS #MAHA #USpol
Here's a rare positive story—Australia is on track to eliminate cervical cancer. Eliminate it altogether.
"In 2021, there were no cervical cancer cases diagnosed in women under 25 for the first time since records began in 1982"
www1.racgp.org.au/newsgp/clini…
#News #GoodNews #Cancer #Health #Australia #WomensHealth #Vaccination
newsGP - Australia set for world-first cervical cancer elimination
Vaccination programs have played a key role, and GPs remain ‘instrumental’ in boosting screening rates to reach the 2035 target.NewsGP
RE: mastodon.com.br/@xkcd/11560680…
was not emotionally prepared to read this and am now ugly crying.
early next year* i go in for what could be my last 6 month post- breast #cancer checkup. if all’s good, then it will be once a year.
i just want more than 15 years of life, cancer-free; even better if they’re fascist-free too.
now back to crying…
* was freaking out earlier about how this checkup snuck up on me but tis not til next year and can’t find when it’s coming up. oy. me and my ADHD brain will be the end of me.
In a violation of foundational ethical principles of human participant research, the Trump Administration axed 383 clinical trials.
Of the canceled trials, 118 (31 percent) were for cancers, 97 (25 percent) were for infectious diseases, 48 (12.5 percent) were for reproductive health, and 47 (12 percent) were for mental health.
#trump #medicine #cancer #mentalHealth #us #usa
arstechnica.com/health/2025/11…
Trump admin axed 383 active clinical trials, dumping over 74K participants
It’s a “violation of foundational ethical principles of human participant research.”…Beth Mole (Ars Technica)
